Janus Henderson Group PLC Veru Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.67 - $1.17 $1.59 Million - $2.78 Million
2,371,890 New
2,371,890 $1.71 Million
Q1 2023

May 15, 2023
BUY
$1.16 - $6.41 $17,207 - $95,085
14,834 Added 116.36%
27,582 $31,000
Q3 2022

Nov 14, 2022
SELL
$10.22 - $23.7 $643 - $1,493
-63 Reduced 0.49%
12,748 $147,000
Q2 2022

Aug 15, 2022
BUY
$4.35 - $15.85 $291 - $1,061
67 Added 0.53%
12,811 $144,000
Q1 2022

May 16, 2022
BUY
$4.55 - $6.41 $9 - $12
2 Added 0.02%
12,744 $62,000
Q4 2021

Feb 14, 2022
BUY
$5.89 - $9.73 $75,050 - $123,979
12,742 New
12,742 $75,000

Others Institutions Holding VERU

# of Institutions
122
Shares Held
56.8M
Call Options Held
668K
Put Options Held
531K
View Full List

About VERU INC.

VERU Quotes by TradingView
  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email